Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug...

[cafead]

via An announcement early this month by Mark Cuban’s deep discount drug company that it would sell Coherus Biosciences’ biosimilar version of AbbVie’s Humira has the Illinois drugmaker calling foul.

article source